Medications

Aflibercept in diabetic macular oedema: Added benefit not proven

Since August 2014, aflibercept (trade name Eylea) has been available also for patients with visual impairment due to diabetic macular oedema (DMO). The German Institute for Quality and Efficiency in Health Care (IQWiG) examined ...

Diabetes

Program improves diabetes control in world's poorest children

A nonprofit program that brings diabetes care and education to some of the world's poorest children has successfully improved control of the disease, according to a University of Pittsburgh Graduate School of Public Health ...

page 14 from 25